Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | Growing crisis of drug prices

Growing crisis of drug prices

Share this article Share this article
published Published on Nov 30, 2012   modified Modified on Nov 30, 2012
-The Hindu

India’s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.

Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model — under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs. 

The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close